{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:00:31Z","timestamp":1770746431221,"version":"3.49.0"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Myeloid neoplasms harboring the FIP1L1-PDGFRA\n                      <jats:italic>(F\/P)<\/jats:italic>\n                      fusion gene infrequently manifest as acute cerebral infarction. The F\/P fusion gene induces proliferation within the eosinophilic lineage, resulting in a clonal hypereosinophilic syndrome that may lead to cerebral infarction. This condition demonstrates a high responsiveness to imatinib therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 27-year-old man presented with acute hemiplegia and was found to have significant eosinophilia. Neuroimaging revealed acute-subacute infarcts with concurrent focal stenosis of the right middle cerebral artery. He was diagnosed with F\/P-rearranged myeloid neoplasm associated with myeloid sarcoma. Treatment with low-dose imatinib monotherapy (100 mg\/day) resulted in rapid resolution of both eosinophilia and the vascular stenosis. Over 9 years of follow-up without adjuvant antithrombotic agents, he has maintained sustained molecular remission and normal neurological function, with no recurrent stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This case provides new clinical data for the diagnosis and treatment of this type of eosinophilia, and highlights the importance of early recognition, workup, and treatment. Peripheral hypereosinophilia may cause tissue damage, leading to hypereosinophilic syndrome with cerebral infarction.\n                      <jats:italic>F\/P<\/jats:italic>\n                      + clonal hypereosinophilic syndrome is a rare diagnosis to consider in patients with unexplained cerebral infarction and hypereosinophilia. In these instances, it is imperative to conduct a peripheral blood test for the\n                      <jats:italic>F\/P<\/jats:italic>\n                      fusion gene early in the diagnostic evaluation of hypereosinophilic syndrome. Upon confirmation of the diagnosis, initiation of imatinib therapy should occur promptly. This treatment approach has resulted in a swift and sustained complete cytologic and molecular remission, no recurrence of cerebral infarction, obviating the need for intensive chemotherapy, statins, anticoagulant or anti-platelet agents.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1628690","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T05:21:47Z","timestamp":1770700907000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute hemiplegia as initial presentation in FIP1L1-PDGFRA-rearranged myeloid neoplasm with eosinophilia: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Min","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Neurology, People\u2019s Hospital, Peking University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Neurology, People\u2019s Hospital, Peking University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, People\u2019s Hospital, Peking University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doudou","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Neurology, Jishan County People\u2019s Hospital of Shanxi Province","place":["Shanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology, People\u2019s Hospital, Peking University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People\u2019s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, People\u2019s Hospital, Peking University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.03.042","article-title":"Refining the definition of hypereosinophilic syndrome","volume":"126","author":"Simon","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1769","DOI":"10.1002\/cnr2.1769","article-title":"Fip1l1-pdgfra fusion gene in T-lymphoblastic lymphoma: A case report","volume":"6","author":"Ali","year":"2023","journal-title":"Cancer Rep (Hoboken)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2024.2381170","article-title":"Acute myeloid leukemia with etv6::Chic2 fusion gene: \u2018Pitfalls\u2019 in diagnosis","volume":"29","author":"Ma","year":"2024","journal-title":"Hematology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.10.023","article-title":"Central nervous system involvement of hypereosinophilic syndrome: A report of 10 cases and a literature review","volume":"347","author":"Lee","year":"2014","journal-title":"J Neurol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2021.100915","article-title":"Literature reviews of stroke with hypereosinophilic syndrome","volume":"37","author":"Ono","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13101795","article-title":"Fip1l1-pdgfralpha-positive loeffler endocarditis-a distinct cause of heart failure in a young male: the role of multimodal diagnostic tools","volume":"13","author":"Varga","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e43138","DOI":"10.7759\/cureus.43138","article-title":"Fip1l1-pdgfra clonal hypereosinophilic syndrome with eosinophilic myocarditis and intracardiac thrombus","volume":"15","author":"Locke","year":"2023","journal-title":"Cureus"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.07032","article-title":"Successful imatinib treatment of cardiac involvement of fip1l1-pdgfra-positive chronic eosinophilic leukemia followed by severe hepatotoxicity","volume":"86","author":"Arai","year":"2007","journal-title":"Int J Hematol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000518","article-title":"Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps","volume":"134","author":"Marx","year":"2019","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25945","article-title":"Epidemiology, clinical picture and long-term outcomes of fip1l1-pdgfra-positive myeloid neoplasm with eosinophilia: data from 151 patients","volume":"95","author":"Rohmer","year":"2020","journal-title":"Am J Hematol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001111","article-title":"Treatment-free remission in fip1l1-pdgfra-positive myeloid\/lymphoid neoplasms with eosinophilia after imatinib discontinuation","volume":"4","author":"Metzgeroth","year":"2020","journal-title":"Blood Adv"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8906","article-title":"Long-term outcomes of imatinib in patients with fip1l1\/pdgfra associated chronic eosinophilic leukemia: experience of a single center in China","volume":"7","author":"Qu","year":"2016","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.529","article-title":"Inflammatory mediator expression within retrieved clots in acute ischemic stroke","volume":"5","author":"Baek","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ejhf.833","article-title":"Abstracts of the heart failure 2017 and the 4th world congress on acute heart failure, paris, France, 29 april - 2 may 2017","author":"Fazal","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"B16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1055\/s-0039-1700502","article-title":"Causes and secondary prevention of acute ischemic stroke in adults","volume":"40","author":"Jensen","year":"2020","journal-title":"Hamostaseologie"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1628690\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T05:21:48Z","timestamp":1770700908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1628690\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":16,"alternative-id":["10.3389\/fonc.2026.1628690"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1628690","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"article-number":"1628690"}}